Drug Trial Radar · NCT07789574
Efficacy of Asciminib in Chronic Phase CML Patients With T315I Mutations
Last checked: Nov 20, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
50
Planned (sponsor's estimate)
Start
Nov 2026
Primary completion
Jun 30, 2030
Study completion Dec 31, 2030
Sponsor
- Lead sponsor
- Thomas Ernst, Prof. Dr. med.Academic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Aug 27, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multi-center, prospective, single-arm, non-randomized, interventional phase II study of CML patients in first or second chronic phase (i.e. after allogeneic stem cell transplantation) and proven BCR::ABL1 T315I mutation. All patients will be treated with asciminib 200 mg BID. 50 patients will be enrolled from approximately 20 study sites in Germany.
Conditions
- Chronic Myeloid Leukemia (CML)
Interventions
asciminib 200 mg BIDDrug
All patients will be treated with asciminib 200 mg BID.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Rate of MR2 at 12 monthsTime frame: 12 months after start of therapy
Locations
10 sites in 1 country. Site status is shown where the registry gives one.
Uniklinik der RWTH Aachen
Aachen, Germany · Recruiting
Charite CVK
Berlin, Germany · Not yet recruiting
Klinikum Chemnitz gGmbH
Chemnitz, Germany · Not yet recruiting
Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden
Dresden, Germany · Not yet recruiting
Universitätsklinikum Hamburg-Eppendorf
Hamburg, Germany · Not yet recruiting
Medizinische Hochschule Hannover
Hanover, Germany · Not yet recruiting
Universitätsklinikum Jena
Jena, Germany · Recruiting
Universitätsklinikum Leipzig AöR
Leipzig, Germany · Recruiting
Medizinische Fakultät Mannheim der Universität Heidelberg
Mannheim, Germany · Recruiting
Universitätsklinikum Ulm
Ulm, Germany · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.